These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1991840)

  • 1. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment.
    Santos MT; Valles J; Marcus AJ; Safier LB; Broekman MJ; Islam N; Ullman HL; Eiroa AM; Aznar J
    J Clin Invest; 1991 Feb; 87(2):571-80. PubMed ID: 1991840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment.
    Valles J; Santos MT; Aznar J; Marcus AJ; Martinez-Sales V; Portoles M; Broekman MJ; Safier LB
    Blood; 1991 Jul; 78(1):154-62. PubMed ID: 1712639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo.
    Vallés J; Santos MT; Aznar J; Martínez M; Moscardó A; Piñón M; Broekman MJ; Marcus AJ
    Blood; 2002 Jun; 99(11):3978-84. PubMed ID: 12010797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins.
    Valles J; Santos MT; Marcus AJ; Safier LB; Broekman MJ; Islam N; Ullman HL; Aznar J
    J Clin Invest; 1993 Sep; 92(3):1357-65. PubMed ID: 7690778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effect of erythrocytes on the platelet reactivity to collagen in IDDM patients.
    Vallés J; Santos MT; Aznar J; Velert M; Barberá G; Carmena R
    Diabetes; 1997 Jun; 46(6):1047-53. PubMed ID: 9166678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosanoid synthesis by purified thrombocytes and erythrocytes from warm- and cold-acclimated American bullfrogs (Rana catesbeiana).
    Wang X; Herman CA
    Gen Comp Endocrinol; 1997 Apr; 106(1):138-44. PubMed ID: 9126474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual platelet thromboxane A2 and prothrombotic effects of erythrocytes are important determinants of aspirin resistance in patients with vascular disease.
    Santos MT; Valles J; Lago A; Tembl J; Sánchez E; Moscardo A; Cosin J
    J Thromb Haemost; 2008 Apr; 6(4):615-21. PubMed ID: 18221358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin.
    Santos MT; Valles J; Aznar J; Marcus AJ; Broekman MJ; Safier LB
    Circulation; 1997 Jan; 95(1):63-8. PubMed ID: 8994418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
    Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA
    Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
    Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition.
    Badr Eslam R; Lang IM; Kaider A; Panzer S
    Transl Res; 2013 May; 161(5):414-20. PubMed ID: 23313628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tris on responses of human and rabbit platelets to aggregating agents.
    Packham MA; Guccione MA; Nina M; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1984 Apr; 51(2):140-4. PubMed ID: 6429880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.
    Marcus AJ; Weksler BB; Jaffe EA; Broekman MJ
    J Clin Invest; 1980 Nov; 66(5):979-86. PubMed ID: 6776148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
    Grüner S; Prostredna M; Aktas B; Moers A; Schulte V; Krieg T; Offermanns S; Eckes B; Nieswandt B
    Circulation; 2004 Nov; 110(18):2946-51. PubMed ID: 15505105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187.
    Kinlough-Rathbone RL; Packham MA; Reimers HJ; Cazenave JP; Mustard JF
    J Lab Clin Med; 1977 Oct; 90(4):707-19. PubMed ID: 333044
    [No Abstract]   [Full Text] [Related]  

  • 20. Normal platelet activation profile in patients with peripheral arterial disease on aspirin.
    van Geffen JP; Kleinegris MC; Verdoold R; Baaten CC; Cosemans JM; Clemetson KJ; Ten Cate H; Roest M; de Laat B; Heemskerk JW
    Thromb Res; 2015 Mar; 135(3):513-20. PubMed ID: 25600441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.